Page last updated: 2024-11-07

penicillamine and Dyslipidemias

penicillamine has been researched along with Dyslipidemias in 1 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bruguera-Àvila, N1
Sánchez-Martínez, E1
Garcia-Olivé, I1
Pérez-Ochoa, JF1
Martínez-Barenys, C1
Ruiz-Manzano, J1

Other Studies

1 other study available for penicillamine and Dyslipidemias

ArticleYear
Obliterating bronchiolitis in a patient treated with (D)-penicillamine.
    Archivos de bronconeumologia, 2013, Volume: 49, Issue:9

    Topics: Bronchiolitis Obliterans; Bronchodilator Agents; Chelating Agents; Chelation Therapy; Combined Modal

2013